Hello and Welcome to Patientsville.com, Your Source for all BUPRENORPHINE information. We are dedicated to provide You with BUPRENORPHINE safety information. Learn about BUPRENORPHINE serious adverse events reported to Food and Drug Administration (FDA).
BUPRENORPHINE Safety Reports
Total BUPRENORPHINE reports: 306. BUPRENORPHINE FDA safety alerts: 2003 . Reported deaths: 48 Reported hospitalizations: 152. Read More Here.< Previous Showing 151-200 of 306 Next >
Health Professional from UNITED KINGDOM reported BUPRENORPHINE problem on Apr 03, 2006. Male patient, 42 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hallucination. BUPRENORPHINE dosage: unknown. Patient recovered.BUPRENORPHINE problem was reported by a Physician from UNITED STATES on Mar 31, 2006. Female patient, 39 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, faeces discoloured, gallbladder disorder, hepatitis, restlessness. BUPRENORPHINE dosage: unknown. During the same period patient was treated with METHADONE, MORPHINE SULPHATE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported BUPRENORPHINE problem on Mar 27, 2006. Female patient, 23 years of age, was diagnosed with sleep disorder and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin graft, skin ulcer. BUPRENORPHINE dosage: unknown. During the same period patient was treated with FLUNITRAZEPAM, ALIMEMAZINE TARTRATE, DIAZEPAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Male patient, 49 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: constipation, impaired gastric emptying, vomiting. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported BUPRENORPHINE problem on Apr 06, 2006. Female patient, weighting 175.2 lb, was diagnosed with lung infection and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cough, decreased appetite, disorientation, dyspnoea, weight decreased. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DIAZEPAM, BUPROPION HYDROCHLORIDE, MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Physician from UNITED STATES on Apr 05, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 11, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abscess. BUPRENORPHINE dosage: unknown. Patient recovered.
BUPRENORPHINE problem was reported by a Physician from FRANCE on Apr 11, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abscess. BUPRENORPHINE dosage: unknown. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 11, 2006. Female patient, 35 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, cyanosis, epidermal necrosis, hepatitis c, inflammation, purpura. BUPRENORPHINE dosage: unknown. Patient was hospitalized and became disabled. Patient died.
BUPRENORPHINE problem was reported by a Physician from FRANCE on Apr 11, 2006. Male patient, 30 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, inflammation, leukocytosis, necrosis. BUPRENORPHINE dosage: unknown. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 11, 2006. Male patient, 30 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, inflammation, leukocytosis, necrosis. BUPRENORPHINE dosage: unknown. Patient recovered.
BUPRENORPHINE problem was reported by a Physician from FRANCE on Apr 11, 2006. Female patient, 35 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, cyanosis, epidermal necrosis, hepatitis c, inflammation, purpura. BUPRENORPHINE dosage: unknown. Patient was hospitalized and became disabled. Patient died.
Health Professional from UNITED KINGDOM reported BUPRENORPHINE problem on Apr 11, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: intentional overdose. BUPRENORPHINE dosage: unknown. During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Apr 11, 2006. Male patient, 36 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. BUPRENORPHINE dosage: unknown. During the same period patient was treated with ALIMEMAZINE TARTRATE, HELICIDINE, FOSINOPRIL. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 11, 2006. Male patient, 40 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site abscess, vein disorder. BUPRENORPHINE dosage: unknown. During the same period patient was treated with HEROIN. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Apr 11, 2006. Male patient, 30 years of age, weighting 136.7 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: disability, inflammation, oedema peripheral. BUPRENORPHINE dosage: unknown. During the same period patient was treated with HEROIN. Patient recovered.
Physician from UNITED STATES reported BUPRENORPHINE problem on Apr 05, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: pitting oedema. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Physician from FRANCE on Apr 11, 2006. Male patient, 30 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, inflammation, leukocytosis, necrosis. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 11, 2006. Male patient, 40 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site abscess, vein disorder. BUPRENORPHINE dosage: unknown. During the same period patient was treated with HEROIN. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Jan 03, 2006. Female patient was diagnosed with detoxification, depression and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: dependence, rhinorrhoea. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DOTHIEPIN HYDROCHLORIDE. Patient died.
Health Professional from GERMANY reported BUPRENORPHINE problem on Apr 18, 2006. Male patient, 34 years of age, weighting 222.7 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: libido decreased. BUPRENORPHINE dosage: 6 -10 MG QD. Patient recovered.
BUPRENORPHINE problem was reported by a Physician from SINGAPORE on Apr 18, 2006. Male patient, 27 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: myositis, rhabdomyolysis, sciatic nerve neuropathy. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported BUPRENORPHINE problem on Jan 03, 2006. Female patient was diagnosed with detoxification, depression and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: dependence, intentional overdose, rhinorrhoea. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DOTHIEPIN HYDROCHLORIDE. Patient died.
BUPRENORPHINE problem was reported by a Physician from FRANCE on Apr 11, 2006. Female patient, 35 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, cyanosis, epidermal necrosis, inflammation, purpura. BUPRENORPHINE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from GERMANY reported BUPRENORPHINE problem on Apr 18, 2006. Male patient, 26 years of age, weighting 141.1 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: libido decreased. BUPRENORPHINE dosage: 6 -10 MG QD. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Apr 11, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: convulsion, orthostatic hypotension. BUPRENORPHINE dosage: unknown. During the same period patient was treated with ALCOHOL. Patient recovered.
Physician from SINGAPORE reported BUPRENORPHINE problem on Apr 18, 2006. Male patient, 31 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: myositis, rhabdomyolysis, sciatic nerve neuropathy. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Apr 24, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: injection site abscess, oedema peripheral, overdose. BUPRENORPHINE dosage: unknown. Patient died.
Physician from FRANCE reported BUPRENORPHINE problem on Apr 24, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from INDIA on Apr 24, 2006. Male patient, 24 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, premature ejaculation, social problem. BUPRENORPHINE dosage: unknown. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE. Patient recovered.
Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on Apr 24, 2006. Male patient, 36 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: lymphoma, nasal mucosal disorder. BUPRENORPHINE dosage: unknown. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from JAPAN on May 02, 2006. Male patient, 73 years of age, was diagnosed with neoplasm malignant and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, sleep disorder. BUPRENORPHINE dosage: 0.2 MG/0.4 MG RC. During the same period patient was treated with MORPHINE SULPHATE, DOMPERIDONE, FAMOTIDINE, POLAPREZINC, ACETAMINOPHEN, CLOSTRIDIUM BUTYRICUM, MAGNESIUM OXIDE. Patient recovered.
Health Professional from FRANCE reported BUPRENORPHINE problem on May 05, 2006. Male patient, 28 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: endocarditis enterococcal, endocarditis staphylococcal, hepatitis c, mitral valve incompetence. BUPRENORPHINE dosage: unknown. During the same period patient was treated with COCAINE. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 03, 2006. Female patient, 22 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: asthma. BUPRENORPHINE dosage: 4 MG. Patient recovered.
Physician from FRANCE reported BUPRENORPHINE problem on May 03, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: erysipelas. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from FRANCE on May 03, 2006. Male patient, 45 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis. BUPRENORPHINE dosage: 16 MG. Patient recovered.
Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on May 03, 2006. Male patient, 36 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: dry skin, erythema, feeling abnormal, panic reaction, persecutory delusion. BUPRENORPHINE dosage: 4 MG. During the same period patient was treated with BROMAZEPAM. Patient recovered.
BUPRENORPHINE problem was reported by a Health Professional from JAPAN on May 02, 2006. Male patient, 73 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination. BUPRENORPHINE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, DOMPERIDONE, FAMOTIDINE, POLAPREZINC, ACETAMINOPHEN, CLOSTRIDIUM BUTYRICUM, MAGNESIUM OXIDE. Patient recovered.
Health Professional from SPAIN reported BUPRENORPHINE problem on May 04, 2006. Male patient, 74 years of age, was diagnosed with pain and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, discomfort. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Pharmacist from FRANCE on May 15, 2006. Male patient was treated with BUPRENORPHINE. BUPRENORPHINE dosage: unknown. During the same period patient was treated with CYAMEMAZINE. Patient was hospitalized. Patient died.
Physician from FRANCE reported BUPRENORPHINE problem on May 03, 2006. Male patient, 44 years of age, weighting 132.3 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, dermatitis, leukocytosis, oedema peripheral. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from JAPAN on May 08, 2006. Male patient, 73 years of age, was diagnosed with neoplasm malignant and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, somnolence. BUPRENORPHINE dosage: 0.2 MG/0.4 MG, 80 MG RC, PO. During the same period patient was treated with BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, DOMPERIDONE, FAMOTIDINE, POLAPREZINC, ACETAMINOPHEN, CLOSTRIDIUM BUTYRICUM, MAGNESIUM OXIDE. Patient recovered.
Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on May 05, 2006. Male patient, 26 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: haematoma, inflammation, injection site necrosis, oedema peripheral. BUPRENORPHINE dosage: 8 MG IA. Patient was hospitalized. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 09, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, dizziness, nystagmus. BUPRENORPHINE dosage: 16 MG/3.6 MG PO. Patient recovered.
Consumer or non-health professional from GERMANY reported BUPRENORPHINE problem on May 11, 2006. Male patient, child 4 years of age, was diagnosed with pain management and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, blood culture positive, blood pressure decreased, diarrhoea, heart rate increased, laboratory test interference, leukopenia, loss of consciousness. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DIMETINDENE, METAMIZOLE, ACETAMINOPHEN. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 03, 2006. Female patient, 47 years of age, was diagnosed with detoxification and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: dependence, intentional overdose, rhinorrhoea. BUPRENORPHINE dosage: 10 MG/70MG/10 MG/70 MG/10 MG; SL. During the same period patient was treated with DOTHIEPIN HYDROCHLORIDE. Patient died.
Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on May 03, 2006. Female patient, 35 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, cyanosis, difficulty in walking, epidermal necrosis, inflammation, purpura. BUPRENORPHINE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 09, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: myoclonus. BUPRENORPHINE dosage: 14 MG TPC. Patient recovered.
Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on Apr 25, 2006. Male patient, 43 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, aortic arteriosclerosis, cardiac disorder, carotid artery stenosis, chest pain, hepatic pain, neurosis. BUPRENORPHINE dosage: 16 MG/12 MG IV. Patient recovered.
BUPRENORPHINE problem was reported by a Consumer or non-health professional from FRANCE on May 09, 2006. Female patient was diagnosed with accidental exposure and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, bladder distension, depressed level of consciousness, dyspnoea, hypoglycaemia, laryngeal dyspnoea, miosis, pyrexia. BUPRENORPHINE dosage: unknown. During the same period patient was treated with OXYBUTYNIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
< Previous Showing 151-200 of 306 Next >